Web4bio releases the new version of DoPlanning

April de 2013

The new version of Web4bio’s flagship productivity tool includes a number of new features, mostly based on suggestions from users.

The most obvious change to appreciate at first glance is its new interface, completely redesigned to be more intuitive and friendly, with new options for viewing and editing content. DoPlanning users can also appreciate the inclusion new work items, such as scheduling tasks, events and issuing interconsultations. DoPlanning interface also includes enhancements in usability, as it allows copying of work items between areas, publishing files simultaneously in several areas or the new ability to upload files directly to an area.

As for their interaction with hardware, developers of this new version have worked hard to improve the accessibility of the application from mobile devices (iPhone, iPad, tablets and smartphones). DoPlanning can now be used from these devices almost as fluently as it is used on a computer, making this application a true mobile workstation from which for example, the user can share images or documents received by email.

The big news however is the possibility of using DoPlanning as web content management system or CMS. The new programming of the application is able to relate the content of any web page with the content and structure of DoPlanning, making maintenance and updating of web contents a very simple task, independent and fully integrated with the other functions of the tool.

DoPlanning

The award won by ASEBIO’s Spanish Biotech Platform shows once more the high quality achieved by Web4Bio.

December 2011

The Spanish Biotech Platform, which has won one of the 2011 Best Ideas in Health Prizes (awarded by the healthcare journal Diario Médico) in the management category, is an initiative conducted by Asebio that aims to improve the way all the different agents involved in the science-technology-business system interact, and therefore to promote innovation and technology transfer in the biotechnology sector.

The use of up-to-date, web 2.0-based communication channels is at the core of the platform in order to achieve its goals. The project was commissioned to Web4Bio, whose team developed a whole system consisting of a web portal, three specialized blogs and a strong presence inside social networks. Recently a partnering tool has been added to the platform, designed to coordinate schedules for all the participants in the different events organized by the Platform. Its corporate image, which serves as a link between the different system components, has also been designed by the team in Web4Bio. Thus, Web4Bio has managed to create a solid, flexible and open online platform which facilitates the exchange of information among all the participants in this Platform.

Web4Bio Launches a New Tool to Organize Partnering Events

November 2011

Developed for the Spanish Biotech Platform managed by Asebio Technical Secretariat, this tool has made possible for the platform to consolidate as a basic pillar in the promotion of public-private partnership within the biotechnology sector. Along these lines, the new Web4Bio application is offered as the most suitable tool to manage and organize customized partnering events.

The application has already been successfully tested at the Regenerative Medicine Forum, held last November 23, 2011 at the National School of Health of the Institute of Health Carlos III, where more than 40 participants managed to organize their schedules and interact through this tool.

Its interface, web based and available in a bilingual format, makes it perfect for both domestic and international events. According to Beatriz Palomo, Coordinator of the Technical Secretariat of the Platform, the tool allows a quick and easy management even when dealing with several partnering events, as it gives attendants a great deal of freedom and flexibility to organize their own schedule while maintaining direct and ongoing contact with others event participants.

BiotechSpain more and more active in social networks

Noviembre de 2011

BiotechSpain the information portal on biotechnology, is increasing its activity inside social networks. If a couple of months ago it was celebrating to have reached 200 followers on Twitter, this month has exceeded 280, so that the barrier of 300 could be overcome by the end of this year if progression continues at this pace.

Not only the great number of followers shows the importance of this initiative-their comments (BiotechSpain has even been recommended as Friday Favourite by Health Spaces Research, managed by the Progress and Health Foundation) also bet on the contents that are regularly added to this portal.

The presence of BiotechSpain in social networks contributes actively to the dissemination of the most recent advances in biotechnology, providing at the same time key information to other agents in the sector. BiotechSpain managers aim to become major players in the web 2.0 biotech world, in order to help form the increasingly active Spanish biotechnology "virtual team".

Web4Bio launches the new Innovatec website

November 2011

The new Innovatec website, developed entirely by Web4Bio, shows the professionalism, scientific skills and capacity of this company, as it has posed a stimulating challenge to its team. This new corporate website adds to the biotech portfolio in Web4Bio.

New Web4Bio monthly newsletter

October 2011

Since October 2011, Web4Bio will send a monthly newsletter for all those whising to stay up to date.
¡Subscribe now!

The portal BiotechSpain reaches 200 followers on twitter.

October 2011

BiotechSpain is emerging as an increasingly helpful portal for those who want to keep up to date on the Spanish biotechnology sector. In our first year we have already got more than 200 followers on Twitter, our growth in popularity bringing us close to other providers of biotechnology information. The BioteschSpain Twitter mainly draws on the news and content included on our site, although we also take into account other channels of information to keep a fluid "social communication" on the net. BiotechSpain expects to continue increasing its followers, by regularly providing information about scientific developments related to biotechnology and news on the sector. Thank you for being a part of it!

The web portal Divestadistica.com, developed by Web4bio, receives an Honorable Mention for the "Science in Action" awards.

July 2011

The web portal divestadistica.com, dedicated to popularization of statistical science and developed by Web4bio for the Andalusian School of Public Health, Granada, won an Honorable Mention in the category of Popular Science Projects, for the "Science in Action" Award Program. The jury gave this mention stating that the site "brings this science closer to the general public in a rigorous, fun and above all, useful way through a wonderful portal for statistical science outreach" In order to provide content and formats tailored for the general public, Web4bio developed an interactive website that includes, among other curiosities a statistical laboratory, which allows users to experience the impact of applying well known statistical laws in various theoretical scenarios.

"Science in Action" is an initiative of the Spanish National Research Council (CSIC), Living Science (Ciencia Viva), the Royal Spanish Physical Society, the Geological Society of Spain and the Spanish Open University, aimed at bringing science and technology to the public. Among its activities, Science in Action holds an annual competition for Spanish or Portuguese teachers, researchers and popularizers willing to submit their projects. This year, the jury emphasized the high quality of all the projects in the competition, which, according to their statement, has made really difficult to choose the best and hindered their final decision. This adds a quality factor to the projects that have been awarded a prize by this initiative.

Web4bio adds Genomica SAU’s corporate website to its web & multimedia portfolio

June 2011

A new environment, more modern and in line with the image of other companies from Zeltia characterizes the new corporate website of Genomica SAU, developed entirely by Web4bio..

Genomica SAU’s new website has been also a challenge from the programming point of view, since the new site incorporates a number of content management applications that enable Genomica SAU a simple and flexible way to communicate with its customers and the ability to keep the site in a fully autonomous way.

With this new corporate website, made for one of the companies belonging to the main biopharmaceutical group in the country, Web4bio strengthens its position as a reference in web development for the biomedical Spanish sector.

Era7 a bioinformatics company makes one of the first functional genome annotations of the Escherichia coli bacteria at the centre of the German outbreak.

June 2011

After the publication by the Chinese genomics center BGI of a preliminary version of the DNA sequence of the E. coli bacteria, which has probably caused the European outbreak starting in Germany, Era7 achieves in less than 24 hours a first functional annotation based on the preliminary assembly by the English scientist Nick Loman.

This has been possible thanks to the "BG7", a method of bacterial genome annotation that the R &D department in Era7 has recently developed and continuous communication over the Internet within the scientific community through blogs, websites and Twitter. The functional annotation is the step that allows us to discern what genes and functions are responsible for its pathogenicity and virulence.

Over 20,000 page views guarantee the quality of BiotechSpain.

May 2011

BiotechSpain accumulates more than 20,000 page views on its way to position itself as the communication specialist in the biotechnology sector. With an average of more than 100 page views daily, Biotechspain is already the preferred place for many surfers who want to keep abreast of the latest developments and events related to biotechnology.

Apart from the specialized content, Biotechspain allows the dissemination of activities and accomplishments of the participants by offering its services free of charge, thus constituting an ideal medium for promoting technology transfer in the sector.

BiotechSpain plans major developments in the near future, including a free repository of 2D and 3D scientific images, and new services to registered members, such as a fully automated news feed adaptable to the web environment of the subscriber.

Era7 participates in the report "Future Model of Health Management", managed by the Bamberg Foundation.

April 2011

On Monday 25 April, coinciding with the twenty-fifth anniversary of the General Law for Health, Bamberg Foundation presented the report "Future Model of Health Management". This report is the result of several months of debate among several dozen experts in various health disciplines. Among them, Dr. Eduardo Pareja, CEO Era7, has provided ideas on the role of genomics and personalized medicine in the medicine of today and tomorrow.

The objective of the report, as explained by the president of the Foundation, Ignacio Para, is to bring together a set of nonpartisan proposals to improve health in Spain.

Era7 invited by the British Embassy to welcome the Prince of Wales in Seville.

June 2011

The British Embassy in Spain organized on April the 1st 2011 a commercial reception in the Seville’s Real Alcazar, aimed at celebrating business relations between Andalusia and the United Kingdom and generate business opportunities in the long term thanks to the visibility and the opportunity provided by the event.

Dr. Eduardo Pareja, CEO of Era7, was invited to the reception where he had the opportunity to interact with leading private and public Andalusian agents along with members of UKTI, what will undoubtedly help to accelerate Era7’s expansion plans in the United Kingdom.

In the photo, from left to right: His Royal Highness the Prince of Wales, Dr. Eduardo Pareja, CEO of Era7, Dr. Bernat Soria, former Minister of Health, and Dr. Angel Cebolla, President of BioAndalucia.

Era7 attends 9th Annual BioPartnering North America 2011

March 2011

Dr. Luis Mancera, CTO of Biomed division in Era7, represents the company in this international event. From 27 February to 1 March Dr. Mancera will present the company to potential partners and collaborators to develop its products, services and activities.

BioPartnering North America is part of the TVG Conference Network, focused on facilitating business development in an open and efficient way. Each year it attracts more than 800 biomedical industry leaders from over 30 countries.

Era7 is an internationally oriented company offering advanced products and services in bioinformatics and information technology specialized in the biomedical sector. Era7 is a Spanish leader in the analysis of DNA sequence data obtained using Next Generation Sequencing technologies. It is also the national reference in state-of-the-art integrated web and multimedia services for the biomedical sector.

Web4bio has developed the official website of the 3d Ascochyta International Congress to be held in Cordoba between 22 and 26 April 2012 February 2011 Through a visually appealing and easy-to-use style, the web offers the potential attendees and participants interested in the event all the information about the congress at the organizational level (program, how to participate, contact, accommodation). It also provides information on other aspects related to the city of Cordoba and its tourist attractions.

Award to HVN (Hospital Virgen de las Nieves) Accesible Signage Project

January 2011

The HVN Accessible Signage Project in Granada, which involved Era7Software participation by developing an application called ‘Virtual Tour’, has been a prizewinner in the IV edition of the Quality Awards in the National Health System 2009, awarded by the Ministry of Health, Social Policy and Equality, in the category of Award for Quality and Equality.

From the application designed for this project Era7Software has developed its service Virtual Tour, which provides a map of any building and a route search on it. Each route can be accessed and printed on the map, and it is also possible to watch a video automatically set that shows the route.

Era7 participates in a Breakfast Conference on the Spanish biotechnology sector

November 2010

On November 24 Era7 participated in a breakfast conference to review and discuss the existing boost measures from institutions and the current framework of competitiveness regarding the Spanish biotech sector.

The event, organized by Gestion Forum, had as speakers to Mr. Juan Tomás Hernani, the secretary general of Innovation at the Ministry of Science and Innovation and Mr. José María Fernández Sousa, chairman of the Spanish Association of Biotechnology Enterprises (ASEBIO). During the debate after the speakers’ intervention, the attendees had the opportunity to raise important issues for the consolidation and development of the biotechnology sector. They discussed the need to professionalise the capital risk associated with biotechnology, innovative measures to support the scientists who decide to start their own business, and alternatives to the brain drain. New ways to foster careers in the field of biosciences, currently in recession, were also explored.

Era7 attends Biospain 2010

October 2010

From September 28 to October 1 a delegation of Era7 attended Biospain 2010, one of the main events for companies and institutions in the biotechnology sector. The objectives of the company focused on establishing contacts and collaborations with other attendees, both in terms of products and services and research related to the company activities. Eduardo Pareja, Era7 CEO, discussed the current state of technologies used in data sequence analysis. His presentation summarized the current state of the main sequencing technologies and mentioned there will be future needs in outsourcing services due to more and more bioinformatic requirements in order to analyze the increasing volume of data. At the forum Biospain 2010 and within the cycle of sessions "Bioinformatic solutions for genomics: from sequence to biotechnology and biomedicine," Dr. Eduardo Pareja, CEO of Era7 Information technologies, gave his talk, "Next generation sequencing real world applications" The paper was intended to foresee future bioinformatics needs, resulting from advances in next generation sequencing (NGS). After analyzing the requirements of current massive genome sequencing systems, Dr. Pareja predicted a growing trend towards outsourcing these services at the expense of "in house" equipment. He also emphasized the benefits of bioinformatics based on "cloud computing" to handle large amounts of data efficiently, safely and quickly at competitive prices.

Era7 accepted as a member of the LLSA (LivingLab Salud de Andalucía, Andalusian Health LivingLab)

June 2010

Living Labs philosophy arises from a new open innovation culture promoted by the European Union.

This new innovation methodology considers users (professionals both in the field to which the Living Lab belongs and in the social environment where solutions are to be implemented and tested) as the main actors in the innovation process from its early stages (identifying needs and conceptualizing ideas) to the validation and improvement of the results achieved.

This project, LLSA (http://livinglabsalud.es), provides an innovation community open to all its members (administration, universities, companies and end users) whose scope for action in the health sector pursues the development of technologies, products and innovative services that meet the real needs of users in the Andalusian Public Health System, being they at the center of the innovation process, from identifying needs and conceptualizing ideas to final validation of the results provided by the developed solution.

LLSA members will help each other through working groups and participation in developing specific projects to meet the needs identified in specific areas of interest to the Andalusian health care sector, such as:

• Telemedicine, teleassistance and telecare
• Robotics and virtual reality
• Biosecurity
• Training and education of health professionals
• Innovative Processes in Healthcare
• Interoperability

In Era7 we will participate in projects suited to our expertise and skills, especially those regarding telemedicine, collaborative tools, e-learning, text analysis, bioinformatics and web & multimedia technologies, as well as Internet technologies in general.

Era7 invited to the ANGLONORDIC BIOTECH CONFERENCE in London

April 2010

Era7 was invited to participate in the seventh edition of the Anglonordic Biotech Conference, held in London on April 15, along with 185 companies and investment funds from the biotech, pharmaceutical and venture capital sectors in the Nordic countries and the United Kingdom. Anglo-Nordic is at present one of the biotech regions with the highest annual worldwide growth rate. This conference has given Era7 a good opportunity to promote its activities in the field of bioinformatics, and to build partnerships with companies operating in the biotechnology and pharmaceutical sector. The event began with a welcome reception at the residence of the Spanish Ambassador in London the previous afternoon, as Spain was the guest on this occasion. Era7 attended the conference along with 13 other Spanish companies and institutions that had the opportunity to participate in different activities at the four areas defined for this meeting: The papers main hall, the Atlas Venture's Investment hall, the individualized work meetings area and the Exhibition Area. Spanish Delegation with the Spanish Ambassador in London.

Overview of the Spanish delegation in the VII Anglonordic Biotech Conference

Era7 opens a new office in Madrid

May 2010

Era7 Information Technologies Ltd., a Bioinformatics Company that provides knowledge based solutions to the biotechnology and biomedical sector, has opened an office in Madrid.

Era7 from its head office at the Technological Park of Health Sciences in Granada has been increasing its portfolio of products and services as well as the number of its customers since 2005.

Currently, Era7 is increasing its presence in the bioinformatics sector especially in DNA massive sequencing (NGS) technologies and also its business lines of web and multimedia specialized in the biomedical sector and software for hospitals and companies.

This growth has pointed out the need for a greater and more stable presence in Madrid.

This way, Era7 intends to offer its customers and partners in Madrid the advantages of proximity and more agility in their services.

The large number of customers Era7 has in Madrid and the undoubted strategic position of the Spanish capital as a focus of attraction for scientific and business activity, all of it made Era7 choose Madrid for their next expansion stage after its recent increase in capital.

The new office is located at 13 Ruiz de Alarcón. 28 014, and the phone number is v>